1.
Maity A, Kar K, D. S, Pandey PK, Sonwani S, Cletus N, Sumeshraj, Kalliath S, Gupta A. Clinical characteristics and outcomes of rivaroxaban 2.5 mg in chronic coronary syndrome: insights from the RICCS India study. Int J Res Med Sci [Internet]. 2025 Oct. 30 [cited 2025 Nov. 13];13(11):4671-5. Available from: https://www.msjonline.org/index.php/ijrms/article/view/15134